Drug profile · INN
caplacizumab-yhdp
CABLIVI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
caplacizumab-yhdp (CABLIVI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN caplacizumab-yhdp
Brand CABLIVI
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is caplacizumab-yhdp?
caplacizumab-yhdp (CABLIVI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for caplacizumab-yhdp?
CABLIVI is a marketed brand name for caplacizumab-yhdp. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of caplacizumab-yhdp?
caplacizumab-yhdp has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.